Study finds US cannabis sector in crisis, but possible rescheduling offers hope

US cannabis rescheduling could eventually lead to companies saving around $2bn a year in federal taxes, a recent cannabis economics report claims.

Recommendations from the US Department of Health and Human Services (HHS) to reschedule cannabis to schedule III under the US Controlled Substances Act are likely to eventually allow businesses to deduct their business expenses on their federal tax returns.

Read full article
I'm already a subscriber
Author default picture

CannIntelligence

This article was written by one of CannIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual cannabis and cannabinoid markets. For a full list, please see our Who We Are page.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization